- Home
- SBH vs NTLA Comparison
SBH vs NTLA Comparison
Compare SBH & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBH
- NTLA
- Stock Information
- Founded
- SBH 1964
- NTLA 2014
- Country
- SBH United States
- NTLA United States
- Employees
- SBH N/A
- NTLA N/A
- Industry
- SBH Other Specialty Stores
- NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SBH Consumer Discretionary
- NTLA Health Care
- Exchange
- SBH Nasdaq
- NTLA Nasdaq
- Market Cap
- SBH 1.3B
- NTLA 1.4B
- IPO Year
- SBH 2006
- NTLA 2016
- Fundamental
- Price
- SBH $12.27
- NTLA $12.91
- Analyst Decision
- SBH Hold
- NTLA Buy
- Analyst Count
- SBH 5
- NTLA 17
- Target Price
- SBH $13.50
- NTLA $56.63
- AVG Volume (30 Days)
- SBH 2.1M
- NTLA 2.5M
- Earning Date
- SBH 01-30-2025
- NTLA 11-07-2024
- Dividend Yield
- SBH N/A
- NTLA N/A
- EPS Growth
- SBH N/A
- NTLA N/A
- EPS
- SBH 1.43
- NTLA N/A
- Revenue
- SBH $3,717,031,000.00
- NTLA $43,086,000.00
- Revenue This Year
- SBH $2.07
- NTLA $52.90
- Revenue Next Year
- SBH $1.61
- NTLA N/A
- P/E Ratio
- SBH $8.59
- NTLA N/A
- Revenue Growth
- SBH N/A
- NTLA N/A
- 52 Week Low
- SBH $9.06
- NTLA $12.47
- 52 Week High
- SBH $14.79
- NTLA $34.87
- Technical
- Relative Strength Index (RSI)
- SBH 38.95
- NTLA 37.06
- Support Level
- SBH $12.17
- NTLA $12.47
- Resistance Level
- SBH $12.63
- NTLA $13.79
- Average True Range (ATR)
- SBH 0.41
- NTLA 0.80
- MACD
- SBH -0.14
- NTLA -0.06
- Stochastic Oscillator
- SBH 9.00
- NTLA 12.10
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Colombia, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About NTLA Intellia Therapeutics Inc.
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.